Walvax Biotechnology Co., Ltd.
300142
株式のランク
#4861
Walvax Biotechnology Co., Ltd. operates as a biological pharmaceutical... Walvax Biotechnology Co., Ltd. operates as a biological pharmaceutical enterprise, dedicated to the research, development, manufacturing, and commercialization of biopharmaceutical products within the Chinese market. Its product portfolio encompasses a range of biomedicines, notably vaccines, blood products, and other related treatments. A significant portion of Walvax's vaccine offerings addresses meningococcal diseases. This includes a Group A, C meningococcal polysaccharide conjugate vaccine for infants up to two years, which prevents conditions such as cerebrospinal meningitis and septicemia. For older children (above two years) and adults, they offer a Group A and C meningococcal polysaccharide vaccine, designed to protect against infections from Neisseria meningitidis serogroups A or C. Furthermore, the company provides a Group ACYW135 meningococcal polysaccharide vaccine, aimed at children over two years old, to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis serogroups A, C, Y, and W135. Beyond meningococcal vaccines, the company supplies a Haemophilus influenzae type b conjugate vaccine, crucial for children aged two months to five years in preventing severe infectious diseases like meningitis, pneumonia, septicemia, cellulitis, arthritis, and epiglottitis. It also manufactures a combined diphtheria, tetanus, and acellular pertussis vaccine for individuals between three months and six years, safeguarding against these three infectious illnesses. Lastly, a 23-valent pneumococcal polysaccharide vaccine is offered for children over two years old, providing immunity against pneumococcal disease caused by 23 distinct serotypes. Established in 2001, Walvax Biotechnology Co., Ltd. maintains its headquarters in Kunming, China.
株価
$1.87
時価総額
$2.98B
変化（1日）
-3.71%
変化（1年）
14.73%
国
CN
取引 Walvax Biotechnology Co., Ltd. (300142)
カテゴリー
Healthcare
Walvax Biotechnology Co., Ltd.（300142）の株式分割履歴
Walvax Biotechnology Co., Ltd.株（シンボル：300142）は合計で5回の株式分割を実施しました。
最新の株式分割はOct 14, 2015に行われました。
May 05, 2011より前に購入された300142株は、現在14.04300142株に相当します。
最新の株式分割はOct 14, 2015に行われました。
May 05, 2011より前に購入された300142株は、現在14.04300142株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2015-10-14 | 3:1 | x3 | x14.04 |
| 2015-04-23 | 2:1 | x2 | x4.68 |
| 2014-05-30 | 13:10 | x1.3 | x2.34 |
| 2012-05-07 | 6:5 | x1.2 | x1.8 |
| 2011-05-05 | 3:2 | x1.5 | x1.5 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
